TP53 and prostate carcinoma: Also, the upregulation of KLF6 significantly reduces cell proliferation in prostate cancer (Narla et al., 2001; Narla et al., 2005; Narla et al., 2007) and in non-small cell lung cancer in a similar way as p53 does (Ito et al., 2004).